The randomized phase 2 clinical trial, led by Rashidi, will study whether FMT improves health outcomes for patients undergoing allogeneic stem cell transplantation, such as less acute GVHD, fewer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback